久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Lifestyle
Home / Lifestyle / Health

Doctor brings AIDS vaccine project from US to Guizhou

By Liu Xiangrui in Beijing and Yang Jun in Guiyang | China Daily | Updated: 2017-04-21 08:09
Share
Share - WeChat

Zhou Xiangyang instructs a student in the Wistar Institute in Philadelphia, the United States. [Photo by Bian Ang/For China Daily]

For Zhou Xiangyang, AIDS research is full of challenges.

After graduating from Chongqing Medical University in 1982, he worked as a doctor in South China in the late 1980s and then went to study in France and the United States.

He joined the Wistar Institute, a Philadelphia-based biomedical research center, in 2007 and has served as its director of viral medicine since.

The 61-year-old has spent years researching HIV/AIDS and oncolytic vaccines, which have brought him international recognition.

According to the World Health Organization, there were about 36.7 million people living with HIV at the end of 2015, and about 46 percent of them were receiving antiretroviral treatment.

Zhou estimates that the number of people with HIV/AIDS in China has quadrupled in the past decade, mainly due to unsafe sex and drug abuse.

He remembers how a young Chinese couple he once treated shocked him and prompted him to strive harder to find a solution to the AIDS problem.

The couple had made their own wealth through hard work but were infected by HIV from taking drugs after they got rich, according to Zhou.

"As a doctor I felt the responsibility to reduce such patients' pain," he says.

He then gradually became involved in research on relevant vaccines.

His team embedded the enveloping protein of HIV into the carrier of chimpanzee adenovirus.

The method enhanced the immunogenicity of the protein.

Zhou says the AIDS prevention vaccine's development has had encouraging results during testing on animals and it has moved to the first phase of clinical trials in the US.

Lo Xiaoping from the QL Pharmaceutical Co Ltd, a company in Guizhou, invited Zhou to bring the vaccine research project to Southwest China's Guizhou province.

Earlier this year, the Chinese company signed a joint development plan with the Wistar Institute in the US.

Lo says Zhou has brought the "seeds" of the vaccine to his company, and the two sides will work together to carry it further.

Much work needs to be done in the near future, says Zhou.

For example, the virus strains from HIV carriers in Asia are different from those in the West, and lots of tests are needed to understand this.

While dealing with HIV/AIDS has been a challenge for doctors in any country, Zhou tells his students to maintain their patience.

As the doctor recalls, his experience of spending a few tough years in rural China when he was very young helped his persistence grow. The quality benefitted him in his research years later.

When he was studying for his PhD in France in the 1990s, he focused on molecular biological research. Back then, few people knew anything about the subject, Zhou says.

He needed to clone genes with methods that required using the enzyme endonuclease to cut the DNA sequence precisely.

But relevant research conditions in France were very poor then. It was hard to find and afford the expensive endonuclease.

He had to be very economical in using the enzyme. There were no other alternatives, either.

To reduce the use of incision enzyme, he had to improve the purity of DNA plasmid he collected from a bacteria and repeat the selection process several times.

As Zhou observes, the gap between China and Western countries in medical research has been narrowing. He believes Guizhou's strategies, including boosting the general health industry have been very positive factors for introducing talent.

"Guizhou has many beneficial factors for our project. It has a nice environment and huge government investment in terms of both capital and talent, which is attractive. We can enhance our competitiveness with more talent," Zhou says of the reason behind choosing Guizhou.

Lo says his company plans to soon recruit PhD-holders who will be sent for training at the Wistar Institute before they return to focus on AIDS-prevention research under Zhou's guidance.

Li Jiaxu contributed to this story.

Related:

Sichuan cross-country runs set for May Day weekend

Family doctors help 'better manage' health

Most Popular
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 日本亚洲综合 | 国产美女精品视频免费观看 | 国产乱理片在线观看夜 | 狠狠色丁香久久婷婷综 | 国产色啪午夜免费视频 | 亚洲va久久久噜噜噜久久狠狠 | 99毛片 | 日韩欧美在线一区二区三区 | 久久久www免费看片 久久久www免费人成看片 | 美女黄色片免费 | 亚洲国产视频在线 | 亚洲加勒比久久88色综合 | 精品国产成人系列 | 国产一及片 | 国产成人精品午夜免费 | 久久精品一区二区国产 | 国产精品极品美女自在线看免费一区二区 | 久久国产a| 91精品一区二区三区在线播放 | 免费在线观看一区 | 手机在线观看精品国产片 | 国产中文字幕视频在线观看 | 污到下面流水的视频 | 久久久欧美综合久久久久 | 免费亚洲视频 | 久久精品人人爽人人爽快 | 国产第一福利影院 | 步兵精品手机在线观看 | v欧美精品v日本精品 | 性生活视频网站 | 失禁h啪肉尿出来高h | 国产一级不卡毛片 | 91成人国产网站在线观看 | 97在线视频免费 | 精品久久久久久亚洲 | 欧美在线精品一区二区三区 | 免费国产黄网站在线观看视频 | 免费人成在线观看网站 | hd欧美xxx欧美极品hd | 成人久久久 | 一级黄一片|